Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 1.9
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic, liver and pancreatic, lungs, prostate, skin, bladder and kidney, and gynecological cancers; and robotic, and neurosurgeons and spine surgery services, as well as treatments for heart diseases. It also...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA
Data is available to registered users only
Buy
Sell